Position of intragastric balloons in global initiative for obesity treatment

Professional paper - Review paper

• Title (croatian): Pozicija intragastričnih balona u globalnoj inicijativi liječenja pretilosti
• Author: Marko Nikolić
• Author: Marko Boban
• Author: Neven Ljubičić
• Author: Vladimir Supanc
• Author: Gorana Mirošević
• Author: Borka Pezo Nikolić
• Author: Vanja Zjačić-Rotkvić
• Author: Petar Gaćina
• Author: Milan Mirković
• Author: Miroslav Bekavac-Bešlin
• Author's institution: University of Zagreb; School of Medicine
• Scientific / art field, discipline and subdiscipline: BIOMEDICINE AND HEALTHCARE; Clinical Medical Sciences

Abstract (english)

Obesity is chronic disease with multiple health consequences and among the most severe health problems worldwide. According to public health records around 65% of population in Croatia are overweight and 20% obese. National physicians chamber with support of Health and Social Welfare Ministry gave recommendations on diagnosing and treating of obesity in form of national consensus. Treatment of obesity is complex and enrolls multiple clinical specialties. Change of life style, strenuous physical activity and pharmacotherapy are part of conservative treatments. Patients are treated more efficiently by minimally invasive endoscopic procedures or bariatric surgery depending on starting body mass index score. Implantation of intragastric balloons is conceptually simple method of obesity treatment. Modern devices as Bio-Enterics intragastric balloons (BIB), (Inamed Health, USA) are gaining wide popularity among both patients and physicians. BIB intragastric offers the best gains with individuals ranging BMI from 35 to 40. Efficiency has relative timeline dependance from 85% at 6 months to 24% at 36 months. BIB offers substantial ameliorative influence on obesity comorbidities, particularly cardiovascular risk. Treatment with BIB is also efficient but transient treatment modality in morbidly and superobese individuals to reduce preoperative risks of general and bariatric surgery. Obesity treatment with BIB is well tolerated and safe, offering better quality of life. Nevertheless, due to relative poor results of conservative obesity treatments on long-term follow up further investigations defining new clinical parameters for solving treatment resistance. In order to provide resourcefully individualized approach modern perspectives are focused on endocrine constitutes of obesity. Hormonal effects of BIB treatment in compare to bariatric surgery are potentially interesting for the prospect studies.

Abstract (croatian)

Debljina je kronična bolest s višestrukim učincima za zdravstveno stanje pojedinca i među najvažnijim zdravstvenim
problemima današnjice. Prema javnozdravstvenim podacima oko 65% populacije Hrvatske je preuhranjeno, a od
toga oko 20% pretilo. Hrvatska liječnička komora u suradnji s Ministarstvom Zdravstva i socijalne skrbi izdali su smjernice
o dijagnostici i liječenju debljine u obliku nacionalnog koncenzusa. Liječenje debljine je kompleksan problem i
uključuje više kliničkih struka. Promjena životnih navika, energična tjelesna aktivnost i farmakoterapija dio su konzervativnog
liječenja. Djelotvorniji se rezultati postižu primjenom barijatrijske kirurgije ili minimalno invanzivnih endoskopskih
zahvata, koji se propisuju obzirom na početni indeks tjelesne mase (ITM). Ugradnja intragastričnih balona

predstavlja konceptualno jednostavan princip liječenja debljine. Suvremeni intragastrični baloni od kojih je najzastupljeniji
BioEnterics-ov(BIB®) (Inamed Health, USA) postaju sve popularniji među bolesnicima i liječnicima. BIB nudi
najbolje rezultate za pojedince sa ITM od 35–40. Učinkovitost intragastričnih balona pokazuje vremensku zavisnost od
85% nakon 6-mjesečnog tretmana do 24% nakon praćenja od 36 mjeseci. BIB poboljšava stanje komorbiditeta debljine,
pogotovo kardiovaskularnog rizika. Liječenje BIB-om također je djelotvorno, ali samo kao privremen oblik liječenja
morbidno i super pretilih osoba na način da smanjuje perioperativni rizik za predstojeću barijatrijsku ili opću kirurgiju.
Liječenje debljine uz pomoć BIB-a je djelotvorno, dobro podnošljivo, sigurno i nudi bolju kvalitetu života. Ukupni rezultati
konzervativnih oblika liječenja debljine mogu se smatrati nezadovoljavajućim na dulji rok, te su potrebna nova
istraživanja za identifikaciju dodatnih kliničkih parametara rezistencije. Kako bi se ponudio učinkovit, prema bolesniku
individualiziran terapijski pristup suvremena istraživanja više su fokusirana na endokrinološke stavke debljine.
Hormonalni učinci BIB liječenja, te usporedba prema barijatrijskoj kirurgiji su potencijalno interesantni za buduća
istraživanja.

• Keywords (english): Bariatric Surgery; Body Mass Index; Gastric Balloon/adverse effects; Humans; Obesity/psychology; Obesity/surgery; Outcome Assessment (Health Care); Quality of Life; Reproducibility of Results; Weight Loss
• Language: english
• Publication type: Professional paper - Review paper
• Publication status: Published
• Peer review: Peer review
• Publication version: Published version
• Journal title: Collegium Antropologicum
• Numbering: vol. 35, no. 4, pp. 1353-1362
• p-ISSN: 0350-6134
• URN:NBN: urn:nbn:hr:105:676846
• Publication: 2011-12
• Document URL: https://hrcak.srce.hr/75693
• Type of resource: Text
• Access conditions: Open access
• Created on: 2024-03-27 19:24:07